CDC6 interaction with ATR regulates activation of a replication checkpoint in higher eukaryotic cells

Kazumasa Yoshida, Nozomi Sugimoto, Satoko Iwahori, Takashi Yugawa, Mako Narisawa-Saito, Tohru Kiyono, Masatoshi Fujita

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)


CDC6, a replication licensing protein, is partially exported to the cytoplasm in human cells through phosphorylation by Cdk during S phase, but a significant proportion remains in the nucleus. We report here that human CDC6 physically interacts with ATR, a crucial checkpoint kinase, in a manner that is stimulated by phosphorylation by Cdk. CDC6 silencing by siRNAs affected ATR-dependent inhibition of mitotic entry elicited by modest replication stress. Whereas a Cdk-phosphorylation-mimicking CDC6 mutant could rescue the checkpoint defect by CDC6 silencing, a phosphorylation-deficient mutant could not. Furthermore, we found that the CDC6-ATR interaction is conserved in Xenopus. We show that the presence of Xenopus CDC6 during S phase is essential for Xenopus ATR to bind to chromatin in response to replication inhibition. In addition, when human CDC6 amino acid fragment 180-220, which can bind to both human and Xenopus ATR, was added to Xenopus egg extracts after assembly of the pre-replication complex, Xenopus Chk1 phosphorylation was significantly reduced without lowering replication, probably through a sequestration of CDC6-mediated ATR-chromatin interaction. Thus, CDC6 might regulate replication-checkpoint activation through the interaction with ATR in higher eukaryotic cells.

Original languageEnglish
Pages (from-to)225-235
Number of pages11
JournalJournal of cell science
Issue number2
Publication statusPublished - 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cell Biology


Dive into the research topics of 'CDC6 interaction with ATR regulates activation of a replication checkpoint in higher eukaryotic cells'. Together they form a unique fingerprint.

Cite this